MLMIC Insurance Company | A Berkshire Hathaway Company
Request a Quote
  • Need to report a claim?
  • Contact
  • LOGIN
  • Why MLMIC+
  • Physicians
  • Groups
  • Hospitals
  • Dentists
  • MLMIC Insider
  • Login
  • Need to Report a Claim?

Tag: FDA

Medical Malpractice Insurance News

News icon

January 24, 2023

Discussing Dietary Supplements with Patients

Given the vast array of dietary supplements on the market—some of which may be ineffective or potentially harmful—it’s more important than ever to discuss these products with patients.

> MORE

Posted in: Hospitals, Physicians

Tagged with: FDA, medication, medication regimen, patient care, patient communication

News icon

March 10, 2021

Individualized Opioid Interventions Can Reduce Use After Surgery

Experts say patient-centric opioid intervention before discharge from the hospital can cut overall opioid intake, while still ensuring a patient is satisfied and their pain is properly managed.

> MORE

Posted in: Hospitals, Physicians

Tagged with: communicating with patients, controlled substance, FDA, medications, opioids, patient safety, prescribers, prescriptions

News icon

March 3, 2021

FDA Issues EUA for Monoclonal Antibody Treatment of COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization for simultaneous administration of monoclonal antibodies bamlanivimab and etesevimab to treat COVID-19 patients who meet specific criteria.

> MORE

Posted in: Hospitals, Physicians

Tagged with: coronavirus, COVID-19, FDA, medications, patient care, patient safety, risk management

News icon

February 18, 2021

FDA Issues Alert on SARS-CoV-2 Viral Mutations and the Associated Impact on Testing

The U.S. Food and Drug Administration is evaluating the potential impact of SARS-CoV-2 viral mutations on authorized molecular tests.

> MORE

Posted in: Hospitals, Physicians

Tagged with: coronavirus, COVID-19, FDA, immunizations, patient safety, reduce risk

News icon

January 26, 2021

FDA Publishes AI/ML-Based Software as a Medical Device Action Plan

The U.S. Food and Drug Administration released an AI/ML-Based Software as a Medical Device Action Plan, which outlines a detailed approach to ensuring the safety and efficacy of these technologies.

> MORE

Posted in: Hospitals, Physicians

Tagged with: FDA, patient safety, reduce risk, regulations, risk management

News icon

December 15, 2020

FDA Cautions Use of Face Masks with Metal During MRIs Poses Patient Safety Risk

The U.S. Food and Drug Administration cautions that patients can be injured if wearing face masks with metal features or coating during an MRI exam.

> MORE

Posted in: Hospitals, Physicians

Tagged with: communicating with patients, coronavirus, COVID-19, FDA, patient harm, patient safety

News icon

November 11, 2020

FDA Grants an EUA for Bamlanivimab to Treat COVID-19 Patients Who Meet Certain Criteria

The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.

> MORE

Posted in: Hospitals, Physicians

Tagged with: coronavirus, COVID-19, FDA, medications, patient care, patient safety, risk management

News icon

October 28, 2020

FDA Approves Veklury for Treatment of COVID-19 Patients Who Meet Certain Criteria

The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.

> MORE

Posted in: Hospitals, Physicians

Tagged with: coronavirus, COVID-19, FDA, medications, patient care, patient safety, risk management

 icon

October 2, 2020

Dental Amalgam Is Safe, Says the American Dental Association

Dental amalgam is “durable, safe and effective” despite containing mercury, the American Dental Association reaffirmed, responding to a recent statement by the Food and Drug Administration.

> MORE

Posted in:

Tagged with: American Dental Association (ADA), FDA, patient safety, reduce risk

News icon

September 30, 2020

FDA Warns About Illicit Online Opioid Retailers

The FDA cautions that a number of websites are illegally selling unauthorized opioids that may be counterfeit, contaminated, expired or otherwise unsafe.

> MORE

Posted in: Hospitals, Physicians

Tagged with: communicating with patients, controlled substance, FDA, medications, opioids, patient safety, prescribers, prescriptions

  1. Pages:
  2. 1
  3. 2
  4. »
  • Request a quote
  • About MLMIC
  • Ask a Specialist
  • Berkshire Hathaway Transaction
  • Careers
  • Contact MLMIC
  • Document Request
  • Medical Malpractice Insurance Cost
  • Apply Now
  • MLMIC Home Page
  • MLMIC Insider
  • Payment Information
  • Professional Societies & Associations
  • Report a Claim
  • Stress Resource Center
  • Testimonials
A.M. Best(R)

Rated a+ by AM Best

70+

Proudly endorsed by more than 70 state, county medical and specialty societies

Copyright © 2023 MLMIC Insurance Company. All rights reserved.

All references to MLMIC refer to MLMIC Insurance Company, Colonie, NY.

  • Follow us on Twitter
  • Follow us on LinkedIn
  • Privacy Policy
  • Terms & Conditions